masoprocol has been researched along with 2019 Novel Coronavirus Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Camacho-Villegas, TA; Canales-Aguirre, AA; Elizondo-Quiroga, DE; García-Ruiz, D; Gutiérrez-Ortega, A; Muñoz-Medina, JE; Villalobos-Sánchez, E | 1 |
1 other study(ies) available for masoprocol and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
In Vitro Antiviral Activity of Nordihydroguaiaretic Acid against SARS-CoV-2.
Topics: Animals; Antiviral Agents; Chlorocebus aethiops; COVID-19; Masoprocol; SARS-CoV-2; Vero Cells | 2023 |